Collections
@industrydocs on Twitter
Industry Documents RSS Feed
Opioid Industry Documents Archive
Teva and Allergan Documents
OIDA staff added 226,880 documents to its newest collection, the Teva and Allergan Documents. This batch brings the collection to more than 1.3 million documents and includes sales training presentations, marketing communications, and more.
The Teva and Allergan collection will encompass about 1.9 million documents when complete. Processed documents are being made public on a rolling basis with monthly releases expected through 2025.
Truth Tobacco Industry Documents
JUUL Labs Collection
2,800+ new documents were posted to the Juul Labs Collection today!
In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL has processed and made available documents subject to public disclosure under Juul Labs’s 2021 settlement with North Carolina.
The IDL is pleased to announce that we have neared completion for the processing of these documents! The project began in December 2023, from which point our archivists have been working to release an average of 240,000 documents every month to our public website. With the onset of 2025, the IDL team has amassed a significantly smaller release of records this January, consisting of documents that required more time-consuming and complicated PII redactions, or some technical challenges that we saved for the end. However, this small release does indicate the majority of the North Carolina Juul Labs documents are now fully available online to our researcher communities.
In the coming months, the IDL archiving team will work through what is left in the NC Juul documents – all files that were originally large ZIP files, the structure of which has been disrupted, and the contents came to the IDL separated as individual records. We have observed that these small files, unfortunately, do not offer much value without the greater context of the original ZIP, and we will work towards reconciling that original structure and release the files accordingly.
New California JUUL Documents Coming Soon
Although we have neared the end of the North Carolina Juul documents, the IDL will soon release additional documents from the California Juul multistate settlement, which was negotiated by the California Department of Justice and six other states in 2023. These forthcoming releases will not be duplicates of the approximately 3 million Juul Labs records already in the IDL but rather are new additions that will further enrich the Juul Labs Collection. Our first release of the new California Juul documents will be coming next month.
Depositions and Trial Transcripts (DATTA)
57 new transcripts of tobacco trial testimony and depositions by Robert Proctor.
Chemical Industry Documents Archive: The Forever Pollution Project Collection
In February 2023, five European countries proposed a PFAS "universal restriction" under the EU chemical regulation REACH (Registration, Evaluation, Authorization and Restriction of Chemicals). The ban would include the entire PFAS chemical 'universe', with some derogations until alternatives are developed. In response, hundreds of industry players have been lobbying decision-makers across Europe to undermine and perhaps kill the proposal.
Over the course of a year, a team of 46 journalists in 16 countries investigated the lobbying and disinformation campaign by the PFAS industry and its allies.
This cross-border, interdisciplinary investigation known as the Forever Lobbying Project collected over 14,000 unpublished documents on PFAS, constituting the world’s largest collection to date on the topic. The majority originate from 184 freedom of information requests, 66 of which were shared with the group by the EU lobby watchdog, Corporate Europe Observatory.
This unique trove of documents was donated by the Forever Lobbying Project and is now available to the public in our new Forever Pollution Project Collection.
Purdue/Sackler settlement under consideration includes document disclosure requirement:
The proposed $7.4 billion settlement with members of the Sackler family and their company, Purdue Pharma (Purdue), includes a provision for document disclosure, which would require Purdue to make public more than 30 million documents related to Purdue and the Sacklers’ opioid business.
According to the Office of the Massachusetts Attorney General, if the settlement is approved, the documents are “expected to be added to the existing public document repository” (UCSF-JHU Opioid Industry Documents Archive) that already houses millions of documents from multiple industries responsible for the crisis.
UCSF and Johns Hopkins University are pleased that these vitally significant documents are one step closer to being made public. The Opioid Industry Documents Archive provides evidence on how and why this crisis happened, so that this type of tragedy can be prevented from occurring again.
We look forward to having the opportunity to contribute our expertise in public health, digital archives, and information technology to enable timely and free public access to these important documents.
Center to End Corporate Harm Launches at UCSF
We are very excited to announce the new UCSF Center to End Corporate Harm!
Products, including fossil fuels, chemicals, alcohol, tobacco and ultra-processed foods are now responsible for approximately one in three deaths worldwide. In the US, a rise in chronic diseases, including cancer (175%), diabetes (283%), Parkinson’s (133%), and dementias (75%), have led to what the scientists say is an “industrial epidemic” of disease.
The Center to End Corporate Harm brings together scientists, researchers, and physicians who study various health-harming industries and, in collaboration with the UCSF Industry Documents Library, are working to identify, analyze, and prevent industry-driven disease and develop strategies to counter the destructive influence of polluters and poisoners.
Could You Be the 2025 UCSF Library Artist in Residence?
The UCSF Library Archives and Special Collections and Makers Lab are accepting proposals for the sixth annual UCSF Library Artist in Residence program. The UCSF Library Artist in Residence award, valued at $8,000, will be given annually to one candidate with a degree in studio arts or a related field or a history of exhibiting artistic work in professional venues. The 2025 residency will begin on July 1, 2025 and end on June 30, 2026.
For more information and application process, please visit the UCSF Library site
UC Love Data Week
The UC Love Data Week is a week-long offering of presentations and workshops focused on data access, management, security, sharing, and preservation. All members of the University of California community are welcome to attend.
The IDL will be featured in the Friday, February 14th session at 3pm:
Unlocking image, audio, and video data in the Industry Documents Library: a Python based, open source stack for audio transcription, text extraction, sentiment analysis, and topic classification
Over the course of a year, a team of 46 journalists in 16 countries investigated an ongoing orchestrated lobbying and disinformation campaign by the PFAS industry and its allies, with the aim of watering down an EU proposal to ban “forever chemicals” and shifting the burden of environmental pollution onto society. The cross-border, interdisciplinary investigation reveals for the first time the staggering cost of cleaning PFAS contamination in Europe if emissions remain unrestricted: €2 trillion over a 20-year period, an annual bill of €100 billion.
PFAS (per- and polyfluoroalkyl substances) are a family of over 10,000 man-made chemicals. Manufactured by a handful of companies, they are widely used in consumer products and industrial processes and equipment, from toilet paper to cable insulation in aircraft. Their miracle properties, however, have fateful downsides. Almost indestructible without human intervention and persistent in living organisms, PFAS have been linked to cancers, immune and hormone disruption, infertility, and other illnesses.
In February 2023, five European countries proposed a PFAS "universal restriction" under the EU chemical regulation REACH (Registration, Evaluation, Authorization and Restriction of Chemicals). The ban would include the entire PFAS chemical 'universe', with some derogations until alternatives are developed. In response, hundreds of industry players have been lobbying decision-makers across Europe to undermine and perhaps kill the proposal.
The team collected over 14,000 unpublished documents on PFAS, constituting the world’s largest collection to date on the topic. The majority originate from 184 freedom of information requests, 66 of which were shared with the group by EU lobby watchdog, Corporate Europe Observatory.
This unique trove of documents is now available to the public in our new Forever Pollution Project Collection.
Read more about the new Forever Lobbying Project, as well as the just-released Corporate Europe Observatory publication 'Chemical Reaction,' an in-depth report exposing the corporate lobby threat to the EU PFAS ban.
As 2024 comes to a close, we’d like to share our gratitude for all of you in the IDL community and your ongoing support and connection to our work.
Here are some of the achievements you helped us reach in 2024:
22,459,816 documents now available through IDL!
If you’re able, please consider making a tax-deductible donation to the Industry Documents Library to help us preserve and provide access to the collections for years to come.
From all of us at the IDL, we wish you a peaceful holiday season, and a healthy and hopeful New Year ahead.
Kate, Rachel, Rebecca, Sven, Melissa, J.A., Emma, and Julie
Truth Tobacco Industry Documents
Juul Labs Collection
117,000+ new documents were posted to the Juul Labs Collection today. This brings the collection to over 2.9 million documents and includes social media reports, marketing campaigns, product complaint logs, product design materials, and more.
In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL continues to process and make available documents subject to public disclosure under JUUL Labs’s 2021 settlement with North Carolina.
Check out “Giant Companies Took Secret Payments to Allow Free Flow of Opioids,” a wonderful in-depth investigation (and use of Opioid Archive documents!) on pharmacy benefit managers (PBMs) by Chris Hamby for the New York Times. Learn more about interactions between PBMs and opioid manufacturers like Purdue and Mallinckrodt.
A compilation of OIDA documents cited in the article:
For another perspective on PBMs and the opioid crisis, read Catherine Dunn's October article in Barron's, Confidential Files Detail PBMs’ Backroom Negotiations—and Their Role in the Opioid Crisis.
OIDA staff added 259,000+ documents to its newest collection, the Teva and Allergan Documents. This batch brings the collection to more than 848,000 documents and includes sales training presentations, marketing communications, and more.
The Teva and Allergan collection will encompass about 1.9 million documents when complete. Processed documents are being made public on a rolling basis with monthly releases expected from 2024-2026.
Announcing the OIDA Data Products
Explore our newest resource, OIDA Data Products — tools that can facilitate and inspire research.
We created these datasets to provide access points for data analysis of Opioid Industry Documents. Researchers get a running start on exploring data, benefiting from our work to curate and deduplicate documents, provide a glossary of spreadsheet column names, and more. Users can craft queries online or select a subset of the data for download, allowing them to interact with OIDA data before dedicating time and resources to a full analysis.
“OIDA Data Products reduces some of the barriers to working with OIDA data, helping researchers get a sense of the many gems hidden among OIDA’s millions of documents,” said Kevin Hawkins, OIDA program director for Johns Hopkins University. “Working with data wranglers, statisticians, and developers, we hope these data products will facilitate new research, helping us to better understand the opioid crisis.”
To learn more and access OIDA Data Products, visit https://data.oida-resources.jhu.edu/. 
151,000+ new documents were posted to the Juul Labs Collection today!
This new batch of documents includes social media presence reports, marketing campaigns, focus group findings, product design, and more.
In partnership with the University of North Carolina at Chapel Hill Libraries, the IDL continues to process and make available documents subject to public disclosure under JUUL Labs’s 2021 settlement with North Carolina.
The Opioid Industry Documents Archive (OIDA), a collaborative undertaking between the University of California, San Francisco and Johns Hopkins University, invites you to explore our newest resource, OIDA Data Products—tools that can facilitate and inspire research.
We created these datasets to provide access points for data analysis of OIDA documents. Researchers get a running start on exploring data, benefiting from our work to curate and deduplicate documents, provide a glossary of spreadsheet column names, and more. Users can craft queries online or select a subset of the data for download, allowing them to interact with OIDA data before dedicating time and resources to a full analysis.
“OIDA Data Products reduces some of the barriers to working with OIDA data, helping researchers get a sense of the many gems hidden among OIDA’s millions of documents,” said Kevin Hawkins, OIDA program director for Johns Hopkins University. “Working with data wranglers, statisticians and developers, we hope these data products will facilitate new research helping us to better understand the opioid crisis.”
Current OIDA Data Products include:
OIDA was launched by UCSF and Johns Hopkins in March 2021 as a free public resource. The digital repository includes publicly disclosed documents arising from litigation brought against opioid manufacturers, distributors, pharmacies and consultants by local and state governments and tribal communities.
The Archive contains more than 17.9 million pages in 3.8 million documents and is expected to continue to grow for years to come. Documents are full-text searchable and include an array of relevant materials from many different companies, including emails, memos, presentations, sales reports, budgets, audit reports, Drug Enforcement Administration briefings, meeting agendas and minutes, expert witness reports and trial transcripts.
OIDA may be of use to many different parties, including individuals and communities harmed by the opioid crisis, as well as the media, health care practitioners, students, lawyers, and researchers. Major news outlets such as the Washington Post and New York Times and academic resources like Health Affairs Scholar and the American Journal of Public Health have published investigative reports and analysis using OIDA documents.
To learn more and access OIDA Data Products, visit https://data.oida-resources.jhu.edu/.
